Ключевые слова:
резус-иммунизация, гемолитическая болезнь плода, Т-лимфоциты CD3 , CD4 , СD8 , CD16 , СD20 иммунорегуляторный индекс, II-триместр, В-лимфоциты.Библиографические ссылки
Prevention of Rh D alloimmunization No. 181. American College of Obstetricians and Gynecologists. Obstet Gynecol, 130 (2) (2017), pp. e57-e70, 10.1097/AOG.0000000000002232
The fetus at risk for anemia–diagnosis and management Clinical Guideline #8. Society for Maternal-Fetal Medicine. Am J Obstet Gynecol, 212 (6) (2015), pp. 697-710, 10.1016/j.ajog.2015.01.059
Management of alloimmunization during pregnancy No. 192. American College of Obstetricians and Gynecologists. Obstet Gynecol, 131 (3) (2018), pp. e82-e90, 10.1097/AOG.000000000000 2528
I Moinuddin, C Fletcher, P. Millward Prevalence and specificity of clinically significant red cell alloantibodies in pregnant women—A study from a tertiary care hospital in Southeast Michigan, J Blood Med, 10 (2019), pp. 283-289, 10.2147/JBM.S214118
NL. Van Buren, Perinatal transfusion medicine. BH Shaz, CD Hillyer, MR Gil (Eds.), Transfusion medicine and hemostasis, Elsevier Inc. (2019), pp. 301-312
Жабборов У.У., Расуль-Заде Ю.Г, Исмаилова А.А. «Цитокиновый статус плода при гемолитической болезни с резус-иммунизации матери» Инфекция, иммунитет, фармакология, Ташкент, 2020, №4. Стр.65-69.
L.C. Nwogu, K.J. Jr. Moise, K.L. Klein, H. Tint, B. Castillo, Y. Bai. Successful management of severe red blood cell alloimmunization in pregnancy with a combination of therapeutic plasma exchange, intravenous immune globulin, and intrauterine transfusion. Transfusion, 58 (2018), pp. 677-684
B.L. Houston, R. Govia, A.M. Abou-Setta, G.J. Reid, M. Hadfield, C. Menard, et al. Severe Rh alloimmunization and hemolytic disease of the fetus managed with plasmapheresis, intravenous immunoglobulin and intrauterine transfusion: a case report. Transfus Apher Sci, 53 (2015), pp. 399-402
B. Mayer, L. Hinkson, W. Hillebrand, W. Henrich, A. Salama. Efficacy of antenatal intravenous immunoglobulin treatment in pregnancies at high risk due to alloimmunization to red blood cells. Transfus Med Hemother, 45 (2018), pp. 429-436
E. Maisonneuve, A. Dugas, S. Friszer, C. Toly-Ndour, L. Cariot, F. Dhombres, et al. Effect of intravenous immunoglobulins to postpone the gestational age of first intrauterine transfusion in very severe red blood cell alloimmunization: a case-control study. J Gynecol Obstet Hum Reprod, 50 (2021), Article 102119